CNS Pharmaceuticals, Inc.
CNSP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729427
In the last 90 days, CNS Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 11 institutions reported holding it in 13F filings for Q2 2026, worth $1.34M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in CNS Pharmaceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +3 vs. Q4 2023
- Shares held
- 972.6K
- +637.4K (+190.1%) vs. Q4 2023
- Total value
- $351.0K
- −$74.3K (−17.5%) vs. Q4 2023
- New holders
- 4
- 8 more added
- Sold out
- 1
- 1 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNSP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 11 | $1.34M |
| Q1 2026 | 12 | $348.7K |
| Q4 2025 | 10 | $652.4K |
| Q3 2025 | 8 | $221.5K |
| Q2 2025 | 11 | $421.8K |
| Q1 2025 | 7 | $55.2K |
| Q4 2024 | 21 | $297.3K |
| Q3 2024 | 14 | $75.3K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 19 | $351.0K |
| Q4 2023 | 16 | $425.3K |
| Q3 2023 | 12 | $131.7K |
| Q2 2023 | 12 | $234.4K |
| Q1 2023 | 13 | $190.5K |
| Q4 2022 | 10 | $335.0K |
| Q3 2022 | 21 | $232.0K |
| Q2 2022 | 23 | $343.5K |
| Q1 2022 | 20 | $589.0K |
| Q4 2021 | 24 | $828.0K |
| Q3 2021 | 20 | $1.44M |
| Q2 2021 | 20 | $2.64M |
| Q1 2021 | 19 | $3.04M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding CNS Pharmaceuticals, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Plante Moran Financial Advisors, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 14 | $5 | 0.00% | −198−93.4% | Reduced |
| Global Retirement Partners, LLC | 53 | $19 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 67 | $24 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 241 | $87 | 0.00% | +34+16.4% | Added |
| Bank of America Corp | 779 | $282 | 0.00% | +778+77,800.0% | Added |
| Tower Research Capital LLC (TRC) | 6,772 | $2.45K | 0.00% | +2,797+70.4% | Added |
| XTX Topco Ltd | 18,729 | $6.78K | 0.00% | +8,727+87.3% | Added |
| FSM Wealth Advisors, LLC | 19,084 | $6.91K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 21,898 | $7.00K | 0.00% | +21,898 | New |
| Two Sigma Securities, LLC | 21,806 | $7.89K | 0.00% | +21,806 | New |
| State Street Corp | 22,556 | $8.16K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 27,388 | $9.91K | 0.00% | +27,388 | New |
| Geode Capital Management, LLC | 28,254 | $10.2K | 0.00% | +3,818+15.6% | Added |
| Vanguard Group Inc | 58,369 | $21.1K | 0.00% | 00.0% | Unchanged |
| Smith Anglin Financial, LLC | 90,332 | $32.7K | 0.00% | +40,332+80.7% | Added |
| Citadel Advisors LLC | 91,034 | $33.0K | 0.00% | +91,034 | New |
| Virtu Financial LLC | 94,246 | $34.0K | 0.00% | +81,094+616.6% | Added |
| Armistice Capital, LLC | 471,000 | $170.5K | 0.00% | +349,000+286.1% | Added |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −11,144−100.0% | Sold out |